Immunodiagnostic Systems Holdings logo

IDH - Immunodiagnostic Systems Holdings Share Price

267.5p -2.5  -0.9%

Last Trade - 11:02am

Sector
Healthcare
Size
Small Cap
Market Cap £77.7m
Enterprise Value £51.2m
Revenue £38.5m
Position in Universe 1036th / 1857
Bullish
Bearish
Unlock IDH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IDH Revenue Unlock IDH Revenue

Net Income

IDH Net Income Unlock IDH Revenue

Normalised EPS

IDH Normalised EPS Unlock IDH Revenue

PE Ratio Range

IDH PE Ratio Range Unlock IDH Revenue

Dividend Yield Range

IDH Dividend Yield Range Unlock IDH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IDH EPS Forecasts Unlock IDH Revenue
Profile Summary

Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology. The automated IVD business consists of 25-OH Vitamin D, specialties and instrument sales. The automated IVD business also consists of the sale or placement of its IDS-iSYS instrument, in addition to selling automated assays and consumables for use in these instruments. The Manual IVD business sells manual assays, radio immunoassays (RIA) and ELISA kits (EIA) to labs. Its assay development is focused in the clinical areas, such as calcium metabolism, bone metabolism, chronic kidney disease, hypertension, fertility and growth. Its subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Nordic A/S and Immunodiagnostic Systems France SAS.

Directors
Last Annual March 31st, 2019
Last Interim March 31st, 2019
Incorporated June 4, 2004
Public Since December 24, 2004
No. of Shareholders: n/a
No. of Employees: 283
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (Full)
Shares in Issue 28,784,097
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom
Web http://www.idsplc.com/
Phone +44 191 5190660
Contact ()
Auditors PricewaterhouseCoopers LLP
IDH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IDH
Upcoming Events for IDH
Similar to IDH
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.